Patents by Inventor Wei-Sheng Sun

Wei-Sheng Sun has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Probiotic and probiotic combination for inhibition of vancomycin-resistant enterococci and use thereof
    Patent number: 11504406
    Abstract: A probiotic combination for inhibition of vancomycin-resistant enterococci includes Bacillus coagulans, Lactobacillus rhamnosus CG, Lactobacillus reuteri, and Lactobacillus acidophilus. The probiotic combination can inhibit growth, host cell attachment, or virulence of vancomycin-resistant enterococci, and also can inhibit virulence gene expression of vancomycin-resistant enterococci. The virulence gene includes at least one of asa1, acm, ebpA, ebpB, ebpC, efaA, sagA, esp, sgrA, and scm genes.
    Type: Grant
    Filed: March 13, 2020
    Date of Patent: November 22, 2022
    Assignees: DELTA ELECTRONICS, INC., TAIPEI MEDICAL UNIVERSITY
    Inventors: Shiuh-Bin Fang, Kun-Nan Tsai, Wei-Sheng Sun, Yu-Hsuan Ho, Yuarn-Jang Lee
  • PROBIOTIC AND PROBIOTIC COMBINATION FOR INHIBITION OF VANCOMYCIN-RESISTANT ENTEROCOCCI AND USE THEREOF
    Publication number: 20210060092
    Abstract: A probiotic combination for inhibition of vancomycin-resistant enterococci includes Bacillus coagulans, Lactobacillus rhamnosus CG, Lactobacillus reuteri, and Lactobacillus acidophilus. The probiotic combination can inhibit growth, host cell attachment, or virulence of vancomycin-resistant enterococci, and also can inhibit virulence gene expression of vancomycin-resistant enterococci. The virulence gene includes at least one of asa1, acm, ebpA, ebpB, ebpC, efaA, sagA, esp, sgrA, and scm genes.
    Type: Application
    Filed: March 13, 2020
    Publication date: March 4, 2021
    Inventors: Shiuh-Bin Fang, Kun-Nan Tsai, Wei-Sheng Sun, Yu-Hsuan Ho, Yuarn-Jang Lee